(Q50109451)

25 February 2018

title

The direct cost of patients with multiple sclerosis: a survey from Italian MS centres. (English)

1 reference

25 February 2018

author name string

Berto P

1

1 reference

25 February 2018

Amato M P

2

1 reference

25 February 2018

Bellantonio P

3

1 reference

25 February 2018

Bortolon F

4

1 reference

25 February 2018

Cavalla P

5

1 reference

25 February 2018

Florio C

6

1 reference

25 February 2018

Lugaresi A

7

1 reference

25 February 2018

Montanari E

8

1 reference

25 February 2018

Rottoli M

9

1 reference

25 February 2018

Simone I L

10

1 reference

25 February 2018

Zaffaroni M

11

1 reference

25 February 2018

publication date

20 April 2011

1 reference

25 February 2018

published in

Neurological Sciences

1 reference

25 February 2018

volume

32

1 reference

25 February 2018

issue

6

1 reference

25 February 2018

page(s)

1035-1041

1 reference

25 February 2018

https://scigraph.springernature.com/pub.10.1007/s10072-011-0578-4

exact match

0 references

cites work

The worldwide prevalence of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

Economic evidence in multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

Costs and quality of life for patients with multiple sclerosis in Belgium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

Costs and quality of life of multiple sclerosis in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

Costs and quality of life of patients with multiple sclerosis in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

The economics of multiple sclerosis. Distribution of costs and relationship to disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

The economic cost of multiple sclerosis in Sweden in 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

A comprehensive assessment of the cost of multiple sclerosis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0578-4

Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group.

21 January 2018

1 reference

12 December 2020

Prevalence, expenditures, utilization, and payment for persons with MS in insured populations.

1 reference

12 December 2020

Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects

1 reference

12 December 2020

Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agents

1 reference

12 December 2020

Cost of multiple sclerosis in Europe

1 reference

12 December 2020

Economic consequences of multiple sclerosis for Canadians

1 reference

12 December 2020

Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States

1 reference

12 December 2020

The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy

1 reference

12 December 2020

Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

1 reference

12 December 2020

Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis

1 reference

12 December 2020

10.1007/S10072-011-0578-4

Identifiers

DOI

1 reference

25 February 2018

PubMed ID

21505911

1 reference

25 February 2018